The acquisition of Tegra Medical announced on 14 November 2016 was completed on 30 November 2016. Tegra Medical will therefore be consolidated by SFS Group as of 1 December 2016. This acquisition strengthens SFS's presence and customer base in the rapidly growing medical technology market.

Tegra Medical, a US company based in Franklin, Massachusetts, develops and manufactures primarily disposable products made of metal and plastic for global, leading medical device OEMs. These products are used in orthopaedics, interventional therapies and minimally-invasive surgery.

After the successful completion of the transaction on 30 November 2016, Tegra Medical will be consolidated as per 1 December 2016 and be integrated into the Engineered Components segment as an independent division. Tegra Medical's current executives will continue to manage the company. Tegra Medical's CEO J. Mark King will take a seat on the Group Executive Board of SFS Group and lead the 'Medical' division.

SFS Group AG published this content on 01 December 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 01 December 2016 05:46:10 UTC.

Original documenthttp://www.sfs.biz/en/web/medien/medienmitteilungen/news_detail_35918848.html

Public permalinkhttp://www.publicnow.com/view/5AE22F3DB5FC6F6604F0DF3A72192261F6CCF696